Effects of Progestin on Modulation of the Expression of Biomarkers in Endometriosis
- PMID: 37509675
- PMCID: PMC10377117
- DOI: 10.3390/biomedicines11072036
Effects of Progestin on Modulation of the Expression of Biomarkers in Endometriosis
Abstract
Background: Our study aimed to examine the osteopontin (OPN) serum levels and tissue expression of CD44 and OPN in endometriosis-affected women both undergoing and not undergoing progestin treatment, and also to determine their involvement in the pathogenesis of endometriosis.
Methods: Using an ELISA kit, we evaluated the OPN serum levels of healthy and endometriosis-affected women both undergoing and not undergoing progestin treatment. Immunohistochemical (IHC) analyses were used to assess the endometriotic tissue expressions of CD44 and OPN.
Results: There were statistically significant higher OPN serum levels in the healthy control group compared to the women with endometriosis. Furthermore, there were higher OPN serum levels in the endometriosis-affected women undergoing the progestin treatment, but the difference did not reach statistical significance. In comparison to OPN, CD44 expression was significantly higher in all the endometriotic tissue glands and stroma, regardless of the patient's treatment status. Compared to the group receiving therapy, the OPN levels were higher in the endometriosis group not receiving therapy. OPN's robust cytoplasmic expression seemed to be associated with the non-treatment group.
Conclusion: Endometriosis, CD44, and OPN appear to be closely related. This study suggests that endometriosis that has not been treated has an immunological profile distinct to endometriosis that has received treatment.
Keywords: CD44; endometriosis; immunohistochemistry; osteopontin; progestin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis.Int J Mol Med. 2013 May;31(5):1011-6. doi: 10.3892/ijmm.2013.1325. Epub 2013 Mar 28. Int J Mol Med. 2013. PMID: 23545719 Free PMC article.
-
Immunohistochemical study of osteopontin and L-selectin in a rat endometriosis model and in human endometriosis.Fertil Steril. 2007 Oct;88(4 Suppl):1207-11. doi: 10.1016/j.fertnstert.2007.02.007. Epub 2007 May 4. Fertil Steril. 2007. PMID: 17482182
-
The involvement of osteopontin and matrix metalloproteinase- 9 in the migration of endometrial epithelial cells in patients with endometriosis.Reprod Biol Endocrinol. 2015 Aug 20;13:95. doi: 10.1186/s12958-015-0090-4. Reprod Biol Endocrinol. 2015. PMID: 26289107 Free PMC article.
-
Osteopontin: role in immune regulation and stress responses.Cytokine Growth Factor Rev. 2008 Oct-Dec;19(5-6):333-45. doi: 10.1016/j.cytogfr.2008.08.001. Epub 2008 Oct 25. Cytokine Growth Factor Rev. 2008. PMID: 18952487 Review.
-
Control of osteopontin signaling and function by post-translational phosphorylation and protein folding.J Cell Biochem. 2007 Nov 1;102(4):912-24. doi: 10.1002/jcb.21558. J Cell Biochem. 2007. PMID: 17910028 Review.
Cited by
-
Pathophysiology of Endometriosis: Insights from Immunohistochemical Analysis of Ectopic and Eutopic Tissues.Int J Mol Sci. 2025 Jun 22;26(13):5998. doi: 10.3390/ijms26135998. Int J Mol Sci. 2025. PMID: 40649777 Free PMC article. Review.
References
-
- Poncelet C., Leblanc M., Walker-Combrouze F., Soriano D., Feldmann G., Madelenat P., Scoazec J.Y., Daraï E. Expression of cadherins and CD44 isoforms in human endometrium and peritoneal endometriosis. Acta Obstet. Gynecol. Scand. 2002;81:195–203. doi: 10.1034/j.1600-0412.2002.810302.x. - DOI - PubMed
-
- Sancakli Usta C., Turan G., Bulbul C.B., Usta A., Adali E. Differential expression of Oct-4, CD44, and E-cadherin in eutopic and ectopic endometrium in ovarian endometriomas and their correlations with clinicopathological variables. Reprod. Biol. Endocrinol. 2020;18:116. doi: 10.1186/s12958-020-00673-1. - DOI - PMC - PubMed
-
- Zhao M., Zhang M., Yu Q., Fei W., Li T., Zhu L., Yao Y., Zheng C., Zhang X. Hyaluronic Acid-Modified Nanoplatforms as a Vector for Targeted Delivery of Autophagy-Related Gene to the Endometriotic Lesions in Mice. Front. Bioeng. Biotechnol. 2022;10:918368. doi: 10.3389/fbioe.2022.918368. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous